| 000 | 01055 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250512102415.0 | ||
| 264 | 0 | _c19730109 | |
| 008 | 197301s 0 0 eng d | ||
| 022 | _a0028-3878 | ||
| 024 | 7 |
_a10.1212/wnl.22.11.1160 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCape, C A | |
| 245 | 0 | 0 |
_aMaintenance adrenocorticotropic hormone (ACTH) treatment in myasthenia gravis. _h[electronic resource] |
| 260 |
_bNeurology _cNov 1972 |
||
| 300 |
_a1160-4 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAdrenocorticotropic Hormone _xadministration & dosage |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aEvaluation Studies as Topic |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMyasthenia Gravis _xdrug therapy |
| 700 | 1 | _aUtterback, R A | |
| 773 | 0 |
_tNeurology _gvol. 22 _gno. 11 _gp. 1160-4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1212/wnl.22.11.1160 _zAvailable from publisher's website |
| 999 |
_c4348490 _d4348490 |
||